靶点针对疾病信息22(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
5-HT 2C receptor (HTR2C)
INDICATI
Approved Depression [ICD-11: 6A70-6A7Z]
INDICATI
Approved Migraine [ICD-11: 8A80]
INDICATI
Approved Obesity [ICD-11: 5B80-5B81]
INDICATI
Approved Pain [ICD-11: MG30-MG3Z]
INDICATI
Approved Pituitary gland disorder [ICD-11: 5A60-5A61]
INDICATI
Approved Psychoactive substances use disorder [ICD-11: 6C4G]
INDICATI
Phase 3 Attention deficit hyperactivity disorder [ICD-11: 6A05]
INDICATI
Phase 3 Chronic insomnia [ICD-11: 7A00]
INDICATI
Phase 3 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 3 Parkinsonism [ICD-11: 8A00]
INDICATI
Phase 3 Sleep-wake disorder [ICD-11: 7A00-7B2Z]
INDICATI
Phase 3 Tonus and reflex abnormality [ICD-11: MB47]
INDICATI
Phase 2 Acute diabete complication [ICD-11: 5A2Y]
INDICATI
Phase 2 Psychotic disorder [ICD-11: 6A20-6A25]
INDICATI
Phase 2 Substance abuse [ICD-11: 6C40]
INDICATI
Phase 1 Anxiety disorder [ICD-11: 6B00-6B0Z]